Clinical Trial 53947

Nashville, TN 37203


<b>ADHD - Multiple Locations in the US</b>

Mastering your child’s ADHD symptoms can be a daily struggle

See if they may be eligible to join the MASTERY® study using an innovative Precision Timed ReleaseTM tablet that may last throughout the day.

Find Out More

The study drug is designed as a multi-release tablet that may provide dosing throughout the day (up to 16 hours).

The tablet’s first layer releases within 30 minutes of taking the tablet, the second release will happen approximately 3-4 hours later, and the third and final release is about 7-8 hours later.

The goal is to eliminate the need for a booster dose later in the day, which may prevent a visit to the nurse’s office during the school day and avoid that rebound effect. Rebound is when the medication leaves the system too quickly and causes the ADHD symptoms to return quickly.

Your child may be eligible if they:

  • Are between the ages of 6 and 17 and are not expected to turn 18 during the study.
  • Have been diagnosed with ADHD.
  • Are either unsatisfied with their current ADHD medications or currently not taking any medications.

There are additional study requirements to participate. A study representative will discuss them with you.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.